EichorEICHOR
Condition: Philadelphia Chromosome Positive Chronic Myeloid Leukemia Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
Phase 1 · 4 location(s) · Marlise Luskin, MD · NCT03595917Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyc
Phase 1 · 2 location(s) · University of Kansas Medical Center · NCT03533816Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
EARLY_Phase 1 · 1 location(s) · Omar Aljitawi · NCT03964506A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · 54 location(s) · Novartis Pharmaceuticals · NCT07549516Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
Phase N/A · 1 location(s) · University of California, Irvine · NCT06229860Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT06802315A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Phase 1 · 11 location(s) · Crossbow Therapeutics, Inc. · NCT06994676Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leu
Phase 2 · 4 location(s) · Medical College of Wisconsin · NCT04838041International Chronic Myeloid Leukemia Pediatric Study
Phase N/A · 20 location(s) · Poitiers University Hospital · NCT01281735Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients W
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06904066A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Ph
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06401603Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment
Phase 1 · 1 location(s) · Mendus · NCT07651878Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting C
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05092451Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in C
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06236724Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07375355CML Pediatric ITK Response According to Molecular Identification at Diagnosis
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT05605379Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targ
NA · 17 location(s) · University Hospital, Clermont-Ferrand · NCT06130787Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resis
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT01746836PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML
Phase 2 · 11 location(s) · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT06409936Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, M
Phase 1/Phase 2 · 1 location(s) · Uma Borate · NCT06523556Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
Phase N/A · 5 location(s) · University of Pisa · NCT06119269Asciminib RMP Study
Phase N/A · 17 location(s) · Novartis Pharmaceuticals · NCT05943522Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT05439889Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT073540743'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
Phase 1/Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06757855Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07269470Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06629584Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies
Phase 2 · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT07238712The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
Phase N/A · 15 location(s) · Peking University People's Hospital · NCT06390306
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.